United States coronavirus vaccine market is expected to grow at an impressive rate for the next five years. Coronavirus is an infectious disease and once it infects one person, it spreads at a rapid rate to other people. Coronavirus has spread all over the world and in March 2020, World Health Organization declared coronavirus as a pandemic. Vaccination is an effective way to prevent the spread the pathogens as it reduces the risk of infection by training the body to recognize the infecting virus and prepare the antibodies present in the body to fight against the spread of disease inside the body. Increase in daily death rate of people suffering from coronavirus as it weakens the immune system of body is expected to fuel the coronavirus vaccine market. A large number of people are getting affected by the coronavirus thereby there is huge burden on the healthcare industry and professional who are taking care of patients admitted into the hospital is creating the need for vaccines so as to limit the spread of coronavirus in United States. To fight the novel coronavirus, leading authorities announced lockdown restrictions and imposed a set of precautionary measures and guidelines to ensure the safety of its citizens. Citizens started maintaining social distance and taking all necessary precautions which led to the shutdown of manufacturing units and industries resulting in a major hit on the economic growth of United States.
United States coronavirus vaccine market is segmented into
The major players operating in the United States coronavirus vaccine market are Pfizer Inc., Moderna Inc., Johnson & Johnson, BioNTech SE, Novavax, Inc., among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.
Years considered for this report
Historical Years2016-2019
Base Year2020
Estimated Year2021
Forecast Period2022–2026
Objective of the Study
- To analyze the historical growth of the market size of United States coronavirus vaccine market from 2016 to 2019.
- To estimate and forecast the market size of United States coronavirus vaccine market from 2020 to 2026 and growth rate until 2026.
- To classify and forecast United States coronavirus vaccine market based on type, required number of doses, patient type, end user, regional distribution, and company.
- To identify dominant region or segment in the United States coronavirus vaccine.
- To identify drivers and challenges for United States coronavirus vaccine market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States coronavirus vaccine market.
- To identify and analyze the profile of leading players operating in United States coronavirus vaccine market.
- To identify key sustainable strategies adopted by market players in United States coronavirus vaccine market.
Click here to download the sample
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of manufacturers across the globe. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufacturers who could not be identified due to the limitations of secondary research. Market insights research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
Market insights research calculated the market size of
Key Target Audience
- Coronavirus vaccine manufacturing companies
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to coronavirus vaccine market.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
